S&P 500
7,582.20
+0.03%
Dow Jones
51,018.80
+0.58%
Nasdaq 100
30,344.40
+0.25%
Russell 2000
2,916.31
-0.54%
FTSE 100
10,378.60
-0.32%
Nikkei 225
66,231.90
+0.67%

Health and Healthcare

NovoCure IPO Stumbles Out of the Gate

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

IPO

Thinkstock
NovoCure Ltd. (NASDAQ: NVCR) priced its initial public offering (IPO) of 12.5 million shares at $22 a share, sharply below the original anticipated range of $25 to $29 and even below a revised range of $23 to $24. Shares tumbled to an intra-day low Friday of $18.67, down more than 15% before staging a comeback to around $19.50. The stock opened at $20.16.

NovoCure is a commercial-stage oncology company developing a novel, proprietary therapy called TTFields for the treatment of solid tumor cancers. Joint bookrunners for the offering are JPMorgan, Deutsche Bank and Evercore Partners. Co-managers are Wells Fargo Securities, JMP Securities and Wedbush PacGrow. The underwriters have a 30-day option on an additional 1.125 million shares.

The company sold 7.5 million shares in the IPO and existing shareholders sold 5 million. NovoCure expected to receive $185.5 million in net proceeds at the midpoint of the revised range, if the underwriters took their full over-allotment options. The actual IPO price is about 6.4% below the midpoint of the revised range ($23.50). The $1.50 difference cost the company about $10.5 million, according information included in Thursday’s amended Form S-1 filing.

There were 14 health care IPOs globally in the third quarter, according to IPO ETF manager Renaissance Capital. Those IPOs raised a total of $2.1 billion, compared with a third quarter total of $5.4 billion in 2014 and a second quarter total this year of $4.9 billion. The three best performing of all 42 global IPOs in the quarter were health care companies, and two of the three worst performers were also health care companies.

In mid-afternoon trading, NovoCure’s shares traded down more than 13% at $19.07, in a first-day range of $18.67 to $20.48.

ALSO READ: 2 Deutsche Bank Health Care Focus Stocks With Big Upside Potential

DISCLOSURE:
INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov. Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org). There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event. Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options  Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation.
Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

IPOs This Week: Chinese Education Firm Bright Scholar Aims for $135 Million
Paul Ausick |

IPOs This Week: Chinese Education Firm Bright Scholar Aims for $135 Million

Four IPOs are on the calendar for the week of May 15: three biotech companies and one China-based education company.

IPO News This Week: 10 Offerings Seeking More Than $3 Billion
Paul Ausick |

IPO News This Week: 10 Offerings Seeking More Than $3 Billion

The 10 IPOs on the calendar for the coming week are seeking to raise a combined total of $3.1 billion,…

Paul Ausick |

IPO Preview: A Blizzard of New Offerings Next Week

ThinkstockAs many as 11 companies could be holding initial public offerings (IPOs) next week. The firms run the gamut, from…

Jon C. Ogg |

Health Care REIT Secondary: When The Large Want To Get Larger (HCN)

Some large REITs have ambitions to grow even larger.  News is out that Health Care REIT, Inc. (NYSE: HCN) sold some…

IPO News This Week: Real Estate Giant, Home Speaker Maker Top Week’s 5 IPOs
Paul Ausick |

IPO News This Week: Real Estate Giant, Home Speaker Maker Top Week’s 5 IPOs

After a week that saw 11 IPOs enter the public market, the coming week takes a bit of breather with…

IPOs This Week: Offerings Winding Down in Dog Days of August
Paul Ausick |

IPOs This Week: Offerings Winding Down in Dog Days of August

Three companies concluded successful IPOs last week, but the results were less than hoped for. Just one offering is on…

Paul Ausick |

Multi Packaging, Dimension Therapeutics IPOs Priced Below Range

Multi Packaging Solutions International sold 16.5 million shares at an IPO price of $13 a share, while Dimension Therapeutics priced…

Paul Ausick |

7 Health Care IPOs on Next Week’s Calendar

ThinkstockLast week was not a standout for initial public offerings (IPOs). There were three on the calendar, and only a…

IPOs This Week: $565 Million Sought in 2 Offerings
Paul Ausick |

IPOs This Week: $565 Million Sought in 2 Offerings

There are two IPOs on the calendar this week. The first is a biopharma firm based in Montreal and the…

Top Gaining Stocks

Dell Technologies
DELL • Vol: 42,366,555
NetApp
NTAP • Vol: 15,911,807
ServiceNow
NOW • Vol: 68,243,561
IBM
IBM • Vol: 28,527,546
Hewlett Packard Enterprise
HPE • Vol: 86,996,387

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
Clorox
CLX • Vol: 4,744,001
ResMed
RMD • Vol: 3,526,686
Intel
INTC • Vol: 191,680,425
Skyworks Solutions
SWKS • Vol: 5,407,806